Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

BRNSBRNS
Showing 8 of 11 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in BARINTHUS BIOTHERAPEUTICS PL

GEODE CAPITAL MANAGEMENT, LLC previously held 0 shares of BRNS (BARINTHUS BIOTHERAPEUTICS PL), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$14,228

Total Shares Change

-11,568

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$0.66
0
2026-Q1
Unchanged
11,568
0.0%
$6,6220.0%$0.60
0
2025-Q4
Unchanged
11,568
0.0%
$8,0980.0%$0.68
0
2025-Q3
Unchanged
11,568
0.0%
$14,4600.0%$1.48
0
2025-Q2
Unchanged
11,568
0.0%
$10,5290.0%$0.92
0
2025-Q1
Unchanged
11,568
0.0%
$11,4520.0%$1.05
0
2024-Q4
Unchanged
11,568
0.0%
$13,8810.0%$1.10
0
2024-Q3
Unchanged
11,568
0.0%
$14,2280.0%$1.18
0

Other major holders of BRNS: M&G Plc, TUDOR INVESTMENT CORP ET AL, Alphabet Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used